{"preliminary_commentary":{"by_channel":{"x_thread":12,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT00551369\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[],"indication":"operable stage I/II non-small cell lung cancer","name":"RTOG 0618","nct_id":"NCT00551369","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=rtog-0618-nct00551369. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Stereotactic body radiation therapy (SBRT)","label":"SBRT","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)","NRG Oncology"],"completion_date":{"date":"2018-05-14","type":"ACTUAL"},"conditions":["Lung Cancer"],"enrollment":{"count":33,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"SBRT","otherNames":["Stereotactic body radiation therapy","Stereotactic ablative radiotherapy","SABR"],"type":"RADIATION"}],"last_update":"2019-04-30","lead_sponsor":"Radiation Therapy Oncology Group","official_title":"A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Operable Stage I/II Non-Small Cell Lung Cancer","overall_status":"COMPLETED","phases":["PHASE2"],"primary_completion_date":{"date":"2012-05","type":"ACTUAL"},"primary_outcomes":[{"measure":"Primary Tumor Control at 2 Years","timeFrame":"From start of treatment to 2 years."}],"references":[{"citation":"Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.","pmid":"29852037","type":"DERIVED"}],"start_date":{"date":"2007-12","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery","url":"https://clinicaltrials.gov/study/NCT00551369"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/rtog-0618-nct00551369"}